Search results for "fide"

showing 10 items of 1978 documents

P046 Vitamin D decreases PDIA3 and prevents the enhanced migration of fibroblasts from stricturing Crohn’s disease

2020

Abstract Background Fibrosis is a common complication in Crohn’s disease (CD) patients and fibroblasts play an important role in the fibrogenic process. Low vitamin D (VD) levels and a defective VD-signalling pathway have been reported in CD. VD signals through both vitamin D receptor (VDR) and protein disulfide-isomerase A3 (PDIA3) and we have previously demonstrated that VDR protein levels are reduced in fibroblasts isolated from CD patients and that VD increased VDR expression in these cells (A-2080; ECCO 2019). We aim to analyse here the effect of VD on both PDIA3 protein levels and migration in CD fibroblasts. Methods We used intestinal fibroblasts isolated from surgical resections of …

Crohn's diseasebusiness.industryGastroenterologyMucous membraneGeneral MedicinePDIA3medicine.diseasemedicine.anatomical_structureVitamin D3 ReceptorFibrosismedicineCancer researchVitamin D and neurologybusinessProtein disulfide-isomeraseHormoneJournal of Crohn's and Colitis
researchProduct

2020

Aim: To determine the relevance of features located close to home and further away, our aim was to study associations between older adults' physical activity and self-reported neighborhood destinations and barriers to outdoor mobility categorized by presence and maximal distance from home. Methods: Cross-sectional analyses comprising men and women 79-94 years old (57%) living independently in Central Finland (n = 185). Self-reported physical activity was categorized into lower (≤3 h moderate activity a week) and higher (≥4 h moderate or intense activity a week) activity. Assisted by interviewers, participants located on an interactive map destinations perceived to facilitate and barriers pe…

Cross-sectional study030503 health policy & servicesPublic Health Environmental and Occupational HealthPhysical activityModerate activityDestinationsLogistic regressionConfidence intervalOdds03 medical and health sciences0302 clinical medicineGeographyLower prevalence030212 general & internal medicine0305 other medical scienceDemographyFrontiers in Public Health
researchProduct

High prevalence of oral potentially malignant disorders and risk factors in a semi-urban brazilian city: a population-based cross-sectional study

2021

Background Oral Potentially Malignant Disorders (OPMDs) are defined as lesions with a greater likelihood of progressing to cancer. Population-based studies that evaluate the prevalence of OPMDs are scarce in Brazil. The aim of the present study was to determine the prevalence of OPMDs and associated risk factors in a semi-urban Brazilian population. Material and Methods This is a cross-sectional study, whose universe included individuals aged 40 years or older residing in a medium-sized city of northeastern Brazil. Data collection was divided into two steps: interview and oral examination. The outcome variable was the presence of OPMDs. The predictor variables were sociodemographic characte…

Cross-sectional studyPopulationvirulence factorsc. albicansPopulation basedBivariate analysissymbols.namesakeRisk FactorsOral Cancer and Potentially malignant disordersPrevalenceMedicineHumansPoisson regressioneducationGeneral DentistryUNESCO:CIENCIAS MÉDICASeducation.field_of_studyHigh prevalenceSemi urbanbusiness.industryResearchConfidence intervalCross-Sectional StudiesgenotypingOtorhinolaryngologyleukoplakiasymbolsoral cavitySurgeryMouth NeoplasmsbusinessBrazilDemographyMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Gender differences in the jealousy-evoking effect of rival characteristics

2011

This study examines gender differences in the jealousy-evoking nature of rival characteristics in two Spanish-speaking countries (Argentina and Spain). A total of 388 Spanish students and 444 Argentinean students participated in the study. First, the cross-cultural validity of a Dutch scale containing 56 rival characteristics was examined. A factor analysis distinguished four dimensions (i.e., social power and dominance, physical attractiveness, physical dominance, and social-communal attributes). After the analysis, the final scale contained in total 24 items. Results showed that in Argentina and Spain combined, men experienced more jealousy than women when their rival was more physically …

Cultural StudiesSocial comparison orientationSEX-DIFFERENCESSocial Psychologymedia_common.quotation_subjectJealousyUNITED-STATEScultural differencesrival characteristicsINFIDELITYEVOLUTIONARY PERSPECTIVEDevelopmental psychologyJealousyCultural diversitysocial comparison orientationROMANTIC JEALOUSYmedia_commonPHYSICAL ATTRACTIVENESSPhysical attractivenessContrast (statistics)Social powerINDIVIDUALISM-COLLECTIVISMSELFDominance (ethology)EMOTIONSgender differencesAnthropologyScale (social sciences)PsychologySocial psychologyRESPONSESJournal of Cross-Cultural Psychology
researchProduct

“Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-me…

2008

Abstract We studied the effect of leukotriene D(4) (LTD(4)) on a human bronchial epithelial cell line (16HBE) overexpressing the cysteinyl leukotriene (CysLT) (1) receptor (HBECysLT(1)R), looking at the associated signal transduction mechanisms as well as at effects on inflammatory cell adhesion. The results obtained showed that LTD(4) increases the phosphorylation of extracellular signal-regulated protein kinase (ERK) 1/2 and of the signal transducer and activator of transcription 1 (STAT-1) in serine 727 (STAT-1Ser727), resulting in increased eosinophil adhesion to HBECysLT(1)R, associated with enhanced surface expression of intercellular adhesion molecule (ICAM) 1. Pretreatment with a Cy…

CyclopropanesMAPK/ERK pathwayIndolesBronchiAcetatesSulfidesBiologyCysteinyl leukotriene-1cysteinyl leukotrieneCell LineLeukotriene D4MaleimidesInterferon-gammaCell AdhesionHumansProtein kinase ACells CulturedProtein kinase CReceptors LeukotrienePharmacologyKinaseMEK inhibitorMembrane ProteinsEpithelial CellsIntercellular Adhesion Molecule-1Intercellular adhesion moleculeCell biologyEosinophilsSTAT1 Transcription FactorQuinolinesLeukotriene AntagonistsMolecular MedicinePhosphorylationMitogen-Activated Protein KinasesSignal transduction
researchProduct

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus monteluk…

2004

BACKGROUND: Corticosteroids are considered to be particularly effective in reducing nasal congestion and are therefore recommended as first-line treatment in allergic rhinitis patients with moderate to severe and/or persistent symptoms. OBJECTIVE: We compared the clinical efficacy of fluticasone propionate aqueous nasal spray (FPANS) 200 microg given once daily, administered in mono-therapy or combined therapy with a H1 receptor antagonist (cetirizine, CTZ) or with a leukotriene antagonist (montelukast, MSK), and the combined therapy of CTZ plus MSK in the treatment of patients affected by allergic rhinitis to Parietaria during natural pollen exposure. In addition, we examined the effect of…

CyclopropanesMaleAllergySettore MED/09 - Medicina Internamedicine.medical_treatmentseasonal allergic rhinitisAcetatesGastroenterologyImmunology and AllergyMedicineChildFluticasonepollen seasonRandomized placebo-controlled trialBlood Proteinsrespiratory systemEosinophil Granule ProteinsMiddle AgedCetirizineAnesthesiamontelukastHistamine H1 AntagonistsQuinolineseosinophil cationic proteinDrug Therapy CombinationFemaleeosinophilsmedicine.symptommedicine.drugAdultmedicine.medical_specialtyAdolescentImmunologyNasal congestionSulfidesPlaceboFluticasone propionateDrug Administration ScheduleRibonucleasesDouble-Blind MethodInternal medicineHumansRandomized placebo-controlled trial; fluticasone; cetirizine; montelukast; seasonal allergic rhinitisGlucocorticoidsMontelukastAdministration IntranasalAnalysis of Variancerhinorrheafluticasone propionatebusiness.industrynasal lavageRhinitis Allergic Seasonalmedicine.diseaseCetirizineAndrostadienesParietariaNasal sprayFluticasoneLeukotriene AntagonistsNasal administrationbusinessClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

2013

Asthma is a disease of all ages. This assumption has been challenged in the past, because of several cultural and scientific biases. A large body of evidence has accumulated in recent years to confirm that the prevalence of asthma in the most advanced ages is similar to that in younger ages. Asthma in the elderly may show similar functional and clinical characteristics to that occurring in young adults, although the frequent coexistence of comorbid conditions in older patients, together with age-associated changes in the human lung, may lead to more severe forms of the disease. Management of asthma in the elderly follows specific guidelines that apply to all ages, although most behaviors ar…

CyclopropanesMalePediatricsmedicine.medical_specialtyQuinolineDiseaseReviewSettore MED/10 - Malattie Dell'Apparato Respiratorioairway inflammationAcetatesSulfidesAnti-asthmatic AgentMaintenance therapyleukotriene antagonistmedicineAnti-Asthmatic AgentHumansAnti-Asthmatic AgentsYoung adultMontelukastAsthmaAgedAged 80 and overLeukotrienetreatmentAcetatebusiness.industryagingGeneral MedicineasthmaMiddle Agedmedicine.diseaseClinical trialleukotriene antagonistsPhysical therapyQuinolinesFemaleGeriatrics and GerontologybusinessHumanmedicine.drugClinical Interventions in Aging
researchProduct

Effects of exercise training and montelukast in children with mild asthma

2008

Data from the general population suggest that habitual exercise decreases bronchial responsiveness, but the possible role of exercise in asthmatics is undefined. The leukotriene receptor antagonist montelukast decreases bronchial responsiveness and exercise-induced symptoms in asthmatic children. This randomized study in children with mild asthma evaluated the combined effects of aerobic training for 12 wk and montelukast or placebo on bronchial responsiveness (BHR) to methacholine, exercise-induced bronchoconstriction (EIB), inflammatory markers in exhaled breath condensate (EBC), and asthma exacerbations.Fifty children (mean age +/- SD: 10.2 +/- 2.4 yr) with mild stable asthma were random…

CyclopropanesMaleQuinolineAcetatesSettore BIO/09 - Fisiologiaimmune system diseasesMedicineOrthopedics and Sports MedicineAnti-Asthmatic AgentsChildMethacholine ChlorideLeukotrieneeducation.field_of_studyrespiratory systemExercise TherapyAsthma Exercise-InducedBreath TestsItalyExhalationAnesthesiaQuinolinesFemalemedicine.drugHumanmedicine.medical_specialtyBreath TestBronchoconstrictionPopulationPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseSulfidesSettore MED/10 - Malattie Dell'Apparato RespiratorioInternal medicineAerobic exerciseHumansAnti-Asthmatic AgenteducationMontelukastAsthmabusiness.industryLeukotriene receptorAcetateBronchospirometrymedicine.diseaseAsthmarespiratory tract diseasesPhysical FitnessPhysical FitneExercise TestMethacholinebusiness
researchProduct

Can the response to Omalizumab be influenced by treatment duration? A real-life study

2017

Objective It is unknown whether Omalizumab effectiveness changes over the course of time. Our retrospective real-life study tried to analyze whether Omalizumab response may be influenced by treatment duration. Methods 340 severe asthmatics treated with Omalizumab for different periods of time were recruited. They were subdivided into 4 groups according to the Omalizumab treatment length: 60 months. Omalizumab treatment results (FEV1, exacerbations, ACT, SABA use, asthma control levels, medications used e and ICS doses) were compared. Results ACT, exacerbations, GINA control levels, ICS doses and SABA use were similar in all groups with different Omalizumab treatment durations. Using a linea…

CyclopropanesMaleSevere asthmaTime FactorsTreatment durationQuinolineEffectivenessOmalizumabOmalizumabAcetatesAdrenal Cortex Hormone0302 clinical medicineAdrenal Cortex HormonesRetrospective StudieForced Expiratory VolumeMedicinePharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicineLead (electronics)Adrenergic beta-AgonistConfoundingEffectiveneReal-lifeResponseAdrenergic beta-AgonistsMiddle AgedTreatment OutcomeEffectiveness; Omalizumab; Real-life; Response; Severe asthma; Treatment duration; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)QuinolinesLinear ModelFemaleHumanmedicine.drugAdultPulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorSulfidesSettore MED/10 - Malattie Dell'Apparato RespiratorioTreatment duration03 medical and health sciencesInternal medicineHumansAnti-Asthmatic AgentMontelukastRetrospective StudiesAsthmaAcetatebusiness.industryBiochemistry (medical)Retrospective cohort studymedicine.diseaseAsthmaDiscontinuationSurgery030228 respiratory systemLinear ModelsbusinessPulmonary Pharmacology & Therapeutics
researchProduct

Anti-inflammatory medications for the treatment of pediatric obstructive sleep apnea

2020

CyclopropanesPulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentmedicine.drug_classAnti-Inflammatory AgentsAdministration OralAcetatesSulfidesAnti-inflammatorylaw.inventionRandomized controlled trialAdrenal Cortex HormoneslawInternal medicinemedicineHumansChildAdministration IntranasalMontelukastSleep Apnea Obstructivebusiness.industryInfantmedicine.diseaseObstructive sleep apneaTreatment OutcomeChild PreschoolPediatrics Perinatology and Child HealthQuinolinesLeukotriene Antagonistsbusinessmedicine.drugPaediatric Respiratory Reviews
researchProduct